Geode Capital Management, LLC Adagio Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,597,674 shares of ADGI stock, worth $5.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,597,674

Previous 1,622,221 1.51%

Holding current value

$5.29 Million

Previous $5.37 Million 1.51%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	N/A	-24,547 Reduced 1.51%	1,597,674 $5.29 Million
Q3 2024 Nov 12, 2024	SELL	N/A	-13,680 Reduced 0.84%	1,622,221 $5.37 Million
Q2 2024 Aug 09, 2024	BUY	N/A	1,024,442 Added 167.54%	1,635,901 $5.41 Million
Q1 2024 May 13, 2024	BUY	N/A	30,369 Added 5.23%	611,459 $2.02 Million
Q4 2023 Feb 13, 2024	BUY	N/A	37,430 Added 6.88%	581,090 $1.92 Million
Q3 2023 Nov 13, 2023	BUY	N/A	26,066 Added 5.04%	543,660 $1.8 Million
Q2 2023 Aug 11, 2023	SELL	N/A	-519,603 Reduced 50.1%	517,594 $1.71 Million
Q1 2023 May 15, 2023	BUY	N/A	15,342 Added 1.5%	1,037,197 $3.43 Million
Q4 2022 Feb 13, 2023	BUY	$3.08 - $4.05 $125,072 - $164,462	40,608 Added 4.14%	1,021,855 $1.53 Million
Q3 2022 Nov 14, 2022	BUY	$2.97 - $4.83 $779,791 - $1.27 Million	262,556 Added 36.53%	981,247 $3.07 Million
Q2 2022 Aug 12, 2022	BUY	$2.54 - $4.52 $200,654 - $357,070	78,998 Added 12.35%	718,691 $2.36 Million
Q1 2022 May 13, 2022	BUY	$3.81 - $10.77 $997,869 - $2.82 Million	261,908 Added 69.33%	639,693 $2.92 Million
Q4 2021 Feb 11, 2022	BUY	$6.35 - $47.04 $36,537 - $270,668	5,754 Added 1.55%	377,785 $2.74 Million
Q3 2021 Nov 12, 2021	BUY	$20.88 - $56.08 $7.77 Million - $20.9 Million	372,031 New	372,031 $15.7 Million

Others Institutions Holding ADGI

# of Institutions

Shares Held

64.6M

Call Options Held

2.3K

Put Options Held

2.1K

View Full List

About Adagio Therapeutics, Inc.

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

More about ADGI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Adagio Therapeutics, Inc. Transaction History